Sunday, May 22, 2022
Outlook.com

Serum Institute

SII Seeks Govt's Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical Cancer

SII Seeks Govt's Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical Cancer

"We are ready to manufacture and stockpile qHPV at our own risk in view of early availability of this life-saving vaccine for the citizens of our country," said Prakash Kumar Singh.

15 May 2022
Adar Poonawalla Woos Elon Musk To Invest In Making Tesla Cars In India

Adar Poonawalla Woos Elon Musk To Invest In Making Tesla Cars In India

Musk, who has made a successful $44 billion acquisition bid for Twitter, had in the past asked India to reduce import duties to sell Tesla electric cars but...

08 May 2022

Reduce Time Gap For Covid Vaccine Booster Dose To Six Months: Serum Institute To Govt

Recalling that they could not meet the commitment of exporting vaccines in the first quarter of 2021 due to "so much noise from public and the opposition",...

NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above

NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject...

30 March 2022

Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine

The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).

Advertisement
21 March 2022
Wockhardt, SII Join Hands To Set Up Vaccine Manufacturing Plant In UK

Wockhardt, SII Join Hands To Set Up Vaccine Manufacturing Plant In UK

The collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities along with the...


27 February 2022
SII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults

SII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults

The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28. The vaccine is yet to be...


31 January 2022
Nobody Losing Anything Due To COVID-19 Vaccine Mandates, Centre Tells SC

Nobody Losing Anything Due To COVID-19 Vaccine Mandates, Centre Tells SC

Solicitor General Tushar Mehta told this to a bench comprising Justices L Nageswara Rao and B R Gavai that was hearing a matter in which issues including...


29 December 2021
8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

The two-dose vaccine uses adenoviruses that infect chimpanzees to carry the gene responsible for the spike protein of the novel coronavirus.


28 December 2021
CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

The government had recently permitted the export of 2 crore doses of COVID-19 vaccine Covovax to Indonesia produced in India by SII, as the jab had not yet...


Advertisement

28 December 2021
Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

Covovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SII

The Covovax/Novavax vaccine has recently received Emergency Use Listing (EUL) with the World Health Organisation (WHO), Emergency Use Authorization (EUA) in...


23 October 2021
PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

PM Narendra Modi will be meeting representatives of Indian Covid-19 vaccine manufactures including Serum Institute of India, Bharat Biotech and Dr Reddy's...


21 October 2021
Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.


01 October 2021
Covishield Gets Australian Medicine Regulator's Approval For Incoming Travellers

Covishield Gets Australian Medicine Regulator's Approval For Incoming Travellers

Prime Minister Scott Morrison's office said the Therapeutic Goods Administration (TGA) has advised that Coronavac (Sinovac) and Covishield should be considered...


26 August 2021
Centre To Receive 20 Crores Of Covishield Doses From Serum Institute In September

Centre To Receive 20 Crores Of Covishield Doses From Serum Institute In September

The Pune-based SII has already supplied 12 crore doses of the COVID-19 vaccine in August, they said.


16 August 2021
Centre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector Quota

Centre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector Quota

It has been communicated to the state that these doses should be administered at private hospitals only.


Advertisement

13 August 2021
‘It May Start Blame Game’: Serum Institute’s Cyrus Poonawalla Against Mixing Covid Vaccines

‘It May Start Blame Game’: Serum Institute’s Cyrus Poonawalla Against Mixing Covid Vaccines

The efficacy of this approach has not been proven in field trials involving thousands of participants, Cyrus Poonawalla said


14 August 2021
Serum Institute Chairman Praises Modi Govt For Controlling Red-Tapism And Licence Raj

Serum Institute Chairman Praises Modi Govt For Controlling Red-Tapism And Licence Raj

SII Chairman Dr Cyrus Poonawalla was speaking at the event where he received the Lokmanyat Tilak National Award instituted by the Lokmanya Tilak Trust here.


03 August 2021
Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister

Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister

The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development...


03 August 2021
Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

'Vaccination drive is going on smoothly. It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,' said...


17 July 2021
Not Received Marketing Authorisation Application For Covishield: EU Medical Body

Not Received Marketing Authorisation Application For Covishield: EU Medical Body

While Covishield has an emergency use listing from the WHO, it is yet to receive a similar approval from the European Union.


30 June 2021
Confident That European Union Will Approve Covishield In A Month: Adar Poonawalla

Confident That European Union Will Approve Covishield In A Month: Adar Poonawalla

Serum Institute of India’s Covishield has not received the EU Covid-19 Vaccination Passport due to which those vaccinated with Covishield will not be able to...


29 June 2021
Not Received Any Application Seeking Approval For Covishield: European Medicines Agency

Not Received Any Application Seeking Approval For Covishield: European Medicines Agency

Serum Institute of India’s Covishield has not received the EU Covid-19 Vaccination Passport due to which those vaccinated with Covishield will not be able to...


28 June 2021
Serum CEO Adar Poonawala Assures Help To Indians Facing Travel Issues Due To Covishield Vaccine

Serum CEO Adar Poonawala Assures Help To Indians Facing Travel Issues Due To Covishield Vaccine

The travellers vaccinated with Covishield may not be eligible for the European Union ‘Green Pass’- an immunity document that is meant to ease travel


25 June 2021
Serum Institute Manufacturing First Batch Of Covovax Covid-19 Vaccine, Says Poonawalla

Serum Institute Manufacturing First Batch Of Covovax Covid-19 Vaccine, Says Poonawalla

Taking to Twitter, SII CEO said, 'Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune.'


Advertisement
Advertisement
Advertisement
Advertisement